Master10
Human Body & Medicine20 Concepts & Facts

What Is a Coronary Stent and How Does It Help Keep an Artery Open? GK Facts, Overview & Study Guide

Reviewed by the Master10 Editorial Board for accuracy, clarity and competitive-exam relevance.Editorial Policy
A coronary stent is an expandable, cylindrical mesh tube deployed within diseased coronary arteries during percutaneous coronary intervention. Atherosclerosis causes lipid-rich plaques to accumulate along arterial walls, restricting oxygenated blood supply to cardiac myocardium and provoking angina or acute myocardial infarction. During balloon angioplasty, interventional cardiologists advance a catheter carrying an unexpanded stent across the arterial stenosis. Inflating the miniature balloon expands the metallic scaffold against the vessel wall, compressing atherosclerotic plaque and restoring vascular lumen diameter. Following balloon deflation and catheter withdrawal, the permanent metallic mesh remains embedded within the arterial wall, preventing elastic recoil and preserving coronary blood perfusion.

Coronary interventional cardiology evolved through distinct technological milestones. Andreas Grüntzig performed the first human percutaneous transluminal balloon angioplasty in Zurich in 1977. However, plain balloon procedures frequently suffered from acute vessel closure and late arterial recoil. In 1986, Jacques Puel and Ulrich Sigwart implanted the first human coronary stent, establishing bare-metal stents engineered from medical stainless steel or cobalt-chromium alloys. While bare-metal scaffolds eliminated abrupt elastic collapse, twenty to thirty percent of patients developed in-stent restenosis triggered by exuberant neointimal smooth muscle cell proliferation. This limitation spurred the invention of drug-eluting stents, which release antiproliferative therapeutic compounds such as sirolimus, everolimus, or paclitaxel to suppress vascular tissue overgrowth.

To prevent catastrophic subacute stent thrombosis across newly implanted scaffolds, patients undergo dual antiplatelet therapy combining aspirin with P2Y12 platelet receptor inhibitors such as clopidogrel or ticagrelor. In public health and pharmaceutical governance, coronary stents represent essential medical devices subject to strict affordability oversight. In India, the Union Ministry of Health added coronary stents to the National List of Essential Medicines. Subsequently, the National Pharmaceutical Pricing Authority invoked the Drugs Prices Control Order of 2013 to impose statutory price ceilings on bare-metal and drug-eluting stents. This regulatory intervention slashed patient costs by up to eighty-five percent, democratizing access to lifesaving cardiovascular interventions across tertiary healthcare institutions.

Key Concepts & Self-Assessment20 Key Facts

Review key Coronary Stents: Angioplasty (PCI), Drug-Eluting Scaffolds & Cardiovascular Care exam facts and rate your mastery to track revision.

Progress: 0/20 Rated 0 Mastered 0 Review Later
#1
A coronary stent is an expandable tubular mesh scaffold deployed within stenotic coronary arteries to restore lumen patency and myocardial blood circulation.
#2
Percutaneous coronary intervention combines balloon angioplasty with stent placement, accessing coronary vasculature through the radial artery or femoral artery access routes.
#3
Andreas Grüntzig conducted the first successful human percutaneous balloon angioplasty in 1977, laying the technical foundation for modern catheter-based cardiac interventions.
#4
Jacques Puel and Ulrich Sigwart implanted the first human coronary stent in 1986, followed by Julio Palmaz developing balloon-expandable metallic mesh architecture.
#5
Bare-metal stents prevent acute arterial elastic recoil but historically suffered high twenty to thirty percent in-stent restenosis rates from neointimal hyperplasia.
#6
Neointimal hyperplasia involves excessive vascular smooth muscle cell proliferation and extracellular matrix deposition in response to mechanical vascular wall injury.
#7
Drug-eluting stents incorporate polymer coatings that gradually elute antiproliferative immunosuppressive drugs like sirolimus, everolimus, zotarolimus, or paclitaxel into vessel walls.
#8
Controlled drug release from drug-eluting stents inhibits vascular smooth muscle proliferation, lowering clinical in-stent restenosis rates to below five percent.
#9
Modern coronary stents utilize high-tensile alloys including cobalt-chromium and platinum-chromium, allowing ultrathin struts that improve deliverability and reduce vascular trauma.
#10
Dual antiplatelet therapy combining aspirin with P2Y12 inhibitors like clopidogrel, prasugrel, or ticagrelor is mandatory to prevent lethal acute stent thrombosis.
#11
Stent struts undergo endothelialization over several months, gradually covering the metallic mesh with natural endothelial cells to minimize long-term thrombotic hazards.
#12
Bioresorbable vascular scaffolds engineered from poly-L-lactic acid dissolve over several years, leaving the remodeled vessel free of permanent metallic cages.
#13
Intravascular ultrasound and optical coherence tomography provide high-resolution cross-sectional imaging to verify proper stent strut apposition against the arterial wall.
#14
The Indian government classified coronary stents as essential drugs by adding them to the National List of Essential Medicines in 2016.
#15
India's National Pharmaceutical Pricing Authority capped coronary stent prices in February 2017 under Schedule I of the Drugs Prices Control Order 2013.
#16
The statutory NPPA ceiling slashed retail coronary stent costs by up to eighty-five percent, curbing excessive hospital markups and protecting cardiovascular patients.
#17
Coronary stents treat acute ST-elevation myocardial infarction during primary PCI, reopening totally occluded coronary arteries to salvage ischemic heart muscle.
#18
Coronary artery bypass grafting surgery remains an alternative revascularization strategy for complex multivessel disease, left main coronary stenosis, and diabetic cohorts.
#19
Domestic Indian manufacturers have developed advanced drug-eluting stents, earning international regulatory approvals and reducing reliance on expensive imported cardiovascular hardware.
#20
Post-procedure clinical management requires aggressive risk factor modification, including high-intensity statin therapy, blood pressure control, glycemic regulation, and smoking cessation.

Subject Specialist Commentary

Analytical perspective & practical exam advice from the Master10 academic board

Educator's Insight
The evolution of coronary stents exemplifies how biomedical materials engineering solved complex vascular pathophysiology. Early balloon angioplasty suffered from abrupt elastic recoil, while bare-metal scaffolds encountered neointimal tissue overgrowth. Coating stents with antiproliferative pharmacological agents resolved restenosis, establishing drug-eluting scaffolds as standard clinical care. In developing economies, capping stent prices transformed cardiovascular medicine by reconciling high-technology interventional cardiology with socioeconomic equity and public healthcare accessibility.
For competitive examinations, candidates must distinguish between balloon angioplasty, bare-metal scaffolds, and drug-eluting stents. Memorize key historical pioneers like Andreas Grüntzig and Julio Palmaz, alongside pharmacology terms such as sirolimus and dual antiplatelet therapy. Note India's NPPA regulation under DPCO 2013. To recall the primary clinical objectives of coronary stenting, memorize the acronym OPEN: Occlusion relief, Plaque scaffolding, Endothelial healing, and Neointimal suppression.

Related Knowledge Topics to Discover

Looking for more GK practice?

Explore 52,789+ questions across 65 General Knowledge categories.

Open Interactive Search